Diabetes

Two regimens fail to stop declines in β-cell function

(HealthDay)—Neither glargine followed by metformin nor metformin alone halts the progressive deterioration of β-cell function in youth with impaired glucose tolerance (IGT) or recently-diagnosed type 2 diabetes, according ...

Diabetes

Resistance exercise offers more prolonged glycemic control

(HealthDay)—For patients with type 1 diabetes, resistance exercise is associated with a smaller initial decline in blood glucose compared with aerobic exercise, but offers a more prolonged reduction in post-exercise glycemia, ...

Diabetes

Dapagliflozin improves glucose outcomes in type 1 diabetes

(HealthDay)—In patients with type 1 diabetes, treatment with dapagliflozin for 24 weeks improves time in range, mean glucose, and glycemic variability, according to a study published online April 9 in Diabetes Care.

Diseases, Conditions, Syndromes

Guidelines developed for diabetes management in CKD

(HealthDay)—In a synopsis of the 2020 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline, published online Nov. 10 in the Annals of Internal Medicine, recommendations and practice points are presented ...

Diabetes

Better outcomes in T2DM with no delay in tx intensification

(HealthDay)—For patients with type 2 diabetes, not delaying intensification of oral antidiabetic drugs (OADs) is associated with greater reductions in hemoglobin A1c (HbA1c), and with reduced risks of cardiovascular events ...

Diabetes

Bariatric surgery in T1DM teens doesn't aid glycemic control

(HealthDay)—Despite significant weight loss, improvements in cardiovascular risk factors, and quality of life, bariatric surgery does not necessarily lead to improved glycemic control in adolescents with type 1 diabetes ...

page 6 from 16